Impact of ovarian stimulation on corpus luteum function and embryonic implantation

Journal of Reproductive Immunology

Volumn 55, Issue 1-2, 2002, Pages 123-130

  Tavaniotou, A ^a   Albano, C ^a   Smitz, J ^a   Devroey, P ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

Corpus luteum; Endometrial biopsy; Gonadotrophin releasing hormone; In vitro fertilization; Luteal phase; Luteinizing hormone; Ovarian stimulation

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; CETRORELIX; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FOLLITROPIN; GONADORELIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE;

CONFERENCE PAPER; CORPUS LUTEUM FUNCTION; FERTILIZATION IN VITRO; FOLLICULAR PHASE; GONADORELIN RELEASE; HUMAN; LUTEAL PHASE; LUTEINIZING HORMONE RELEASE; NIDATION; OVULATION; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE RELEASE; STEROID BLOOD LEVEL;

CHORIONIC GONADOTROPIN; CORPUS LUTEUM; EMBRYO IMPLANTATION; ENDOMETRIUM; FEMALE; HUMANS; LUTEAL PHASE; LUTEINIZING HORMONE; OVULATION INDUCTION; PREGNANCY;

EID: 0036286393     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(01)00134-6     Document Type: Conference Paper

References (28)

1. The luteal phase of non supplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix
2. Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles
3. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in vitro fertilization
4. Human endometrial maturation is markedly improved after luteal supplementation of gonadotrophin-releasing hormone analogue/human menopausal gonadotrophin stimulated cycles
5. A pilot study involving minimal ovarian stimulation for in-vitro fertilization: Extending the 'follicle-stimulating hormone window' combined with the gonadotropin releasing hormone antagonist Cetrorelix
6. The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women
7. Expression of gonadotrophin-releasing hormone (GnRH) gene in human uterine endometrial tissue
8. Establishing full-term pregnancies using cleaving embryos grown in-vitro
9. Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility
10. Estrogen-induced human luteolysis
11. Dominant expression and distribution of oestrogen receptor beta over alpha in the human corpus luteum
12. Expression of gap junction protein connexin-43 in the human and baboon (Papio anubis) corpus luteum
13. Disparate effects of endogenous and exogenous oestradiol on luteal phase function in women
14. Gonadotropin releasing hormone receptor gene expression in human ovary and granulosa-lutein cells
15. Expression of oestrogen receptor α and β mRNA in corpus luteum of human subjects
16. Suppression of serum levels of luteinizing hormone by short- and long-loop negative feedback in ovariectomized women
17. Endometrial pinopodes indicate a shift in the window of receptivity in IVF cycles
18. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle
19. Dating the endometrial biopsy
20. Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme
21. The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT
22. Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol
23. Progesterone modulation of pulsatile luteinizing hormone secretion in normal women
24. In vitro fertilization: The degree of endometrial insufficiency varies with the type of ovarian stimulation
25. Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix
26. Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase
27. Progesterone synthesis by human luteal cells: Modulation by estradiol